Pharmacokinetics of second generation antidepressants: bupropion

Bupropion is a relatively dopamine-specific antidepressant approved for release by the Food and Drug Administration in 1989. Topics included in this review are pharmacokinetics as related to blood levels and clinical response, bupropion's use in the elderly and in the medically impaired, and drug interactions of note.